These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 17517842

  • 1. Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents.
    Abdel-Rahman SM, Jacobs RF, Massarella J, Kauffman RE, Bradley JS, Kimko HC, Kearns GL, Shalayda K, Curtin C, Maldonado SD, Blumer JL.
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2668-73. PubMed ID: 17517842
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of intravenous itraconazole followed by itraconazole oral solution in patients with human immunodeficiency virus infection.
    Zhao Q, Zhou H, Pesco-Koplowitz L.
    J Clin Pharmacol; 2001 Dec; 41(12):1319-28. PubMed ID: 11762559
    [Abstract] [Full Text] [Related]

  • 3. A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection.
    Zhou H, Goldman M, Wu J, Woestenborghs R, Hassell AE, Lee P, Baruch A, Pesco-Koplowitz L, Borum J, Wheat LJ.
    J Clin Pharmacol; 1998 Jul; 38(7):593-602. PubMed ID: 9702843
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.
    de Repentigny L, Ratelle J, Leclerc JM, Cornu G, Sokal EM, Jacqmin P, De Beule K.
    Antimicrob Agents Chemother; 1998 Feb; 42(2):404-8. PubMed ID: 9527794
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Linking the concentrations of itraconazole and 2-hydroxypropyl-β-cyclodextrin in human intestinal fluids after oral intake of Sporanox®.
    Berben P, Stappaerts J, Vink MJA, Domínguez-Vega E, Somsen GW, Brouwers J, Augustijns P.
    Eur J Pharm Biopharm; 2018 Nov; 132():231-236. PubMed ID: 29959034
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
    Buchanan CM, Buchanan NL, Edgar KJ, Klein S, Little JL, Ramsey MG, Ruble KM, Wacher VJ, Wempe MF.
    J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units.
    Vandewoude K, Vogelaers D, Decruyenaere J, Jaqmin P, De Beule K, Van Peer A, Woestenborghs R, Groen K, Colardyn F.
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2714-8. PubMed ID: 9420044
    [Abstract] [Full Text] [Related]

  • 15. Enhanced bioavailability of itraconazole in hydroxypropyl-beta-cyclodextrin solution versus capsules in healthy volunteers.
    Barone JA, Moskovitz BL, Guarnieri J, Hassell AE, Colaizzi JL, Bierman RH, Jessen L.
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1862-5. PubMed ID: 9661037
    [Abstract] [Full Text] [Related]

  • 16. Effects of cyclosporine a on single-dose pharmacokinetics of intravenous itraconazole in patients with hematologic malignancies.
    Timmers GJ, Kessels LW, Wilhelm AJ, Veldkamp AI, Bosch TM, Beijnen JH, Huijgens PC.
    Ther Drug Monit; 2008 Jun; 30(3):301-5. PubMed ID: 18520601
    [Abstract] [Full Text] [Related]

  • 17. Hydroxy-itraconazole pharmacokinetics is similar to that of itraconazole in immunocompromised patients receiving oral solution of itraconazole.
    Mino Y, Naito T, Watanabe T, Yamada T, Yagi T, Yamada H, Kawakami J.
    Clin Chim Acta; 2013 Jan 16; 415():128-32. PubMed ID: 23089073
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy.
    Boogaerts MA, Maertens J, Van Der Geest R, Bosly A, Michaux JM, Van Hoof A, Cleeren M, Wostenborghs R, De Beule K.
    Antimicrob Agents Chemother; 2001 Mar 16; 45(3):981-5. PubMed ID: 11181397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.